about
Initiation of rheumatoid arthritis treatments and the risk of serious infections.Adherence to disease-modifying antirheumatic drugs and the effects of exposure misclassification on the risk of hospital admission.Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritisValidation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups.The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis.Rheumatoid arthritis: an overview of new and emerging therapies.Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry.Glucocorticoids: bad or safe for the bones?The Development of Novel Therapies for Rheumatoid ArthritisDepicting and comparing the time to normalize "erythrocyte sedimentation rate" following two combination therapies in rheumatoid arthritis patients: a randomized clinical trialAntirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regenerationOne-year effects of glucocorticoids on bone density: a meta-analysis in cohorts on high and low-dose therapyClinical analysis of chinese patients with rheumatoid arthritis treated with leflunomide and methotrexate combined with different dosages of glucocorticoidSuppression of antibody-mediated arthritis in mice by Fab fragments of the mediating antibodies.Six-year follow-up study of bone mineral density in patients with systemic lupus erythematosus.Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis.Are glucocorticoids harmful to bone in early rheumatoid arthritis?
P2860
Q34019267-647D416F-BFB4-49BE-9A59-B3850A7856B3Q34154483-2DE049D2-7BDA-4E5F-BF61-44E59BE8AEA5Q35581451-449E476D-9D30-4068-BAB1-9D3D987E7826Q35605617-E559FFC1-83CC-4C3A-92AF-AAB28592F6F1Q36132386-5951D141-1608-4BC7-BDDB-3D053E80134FQ36160669-4126618D-5017-4BA3-8539-F6FEEB1CCA94Q36191250-FC0C3C17-93E3-4554-B623-5AE6C50E2606Q36223905-9C0A117E-8408-4EE5-B327-A21CE5491FBEQ36246088-7F007947-D31F-4D27-9BD2-18A52719E088Q36801049-B72A3347-9F30-421B-9BD2-A1188A08A2CFQ37145264-82527A84-6201-467A-BE8B-988AE7266D59Q37207085-54F7DBC9-348C-407D-98B0-11C05E9726B3Q37251693-8BFFE0E7-3DF8-42E5-AACC-0D8F0225DE86Q37636900-1D300B02-0D10-4EA5-B5FC-0DDDE812BF84Q41121882-BE59112F-4EBF-4814-8D46-5426C82893B5Q44427353-A03B3ADE-F1F8-425C-8DFE-C33F1D3CEBC5Q47625115-E812501E-EE89-482B-AAE0-3A847F65ED32Q51741238-6C2D12A9-E6C2-48EF-8C10-D3F32CC132B9
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Glucocorticoids in the treatment of early and late RA
@ast
Glucocorticoids in the treatment of early and late RA
@en
type
label
Glucocorticoids in the treatment of early and late RA
@ast
Glucocorticoids in the treatment of early and late RA
@en
prefLabel
Glucocorticoids in the treatment of early and late RA
@ast
Glucocorticoids in the treatment of early and late RA
@en
P2093
P2860
P356
P1476
Glucocorticoids in the treatment of early and late RA
@en
P2093
P2860
P304
P356
10.1136/ARD.62.11.1033
P407
P577
2003-11-01T00:00:00Z